register

Market Research & Insights

Incredible breadth of Australia’s COVID-19 research: From vaccines to aircon filters

Health Industry Hub | July 12, 2020 |

Market Research & Insights: Since the coronavirus hit Australia’s shores, health and medical researchers have been rapidly redeployed in unprecedented numbers to support the national response.

Research Australia, the national peak body for health and medical research, has released the first report in its COVID-19 series showcasing the incredible breadth of Australia’s COVID-19 research.

“Australians are rightly proud of our world-leading vaccine projects. There’s
incredible work being done beyond the lab too – everything from guidelines for breastfeeding mothers to filters that have the potential to remove the coronavirus from air conditioning systems,” said Research Australia CEO, Nadia Levin.

“The true range of COVID-19 medical research is not evident to the researchers themselves, let alone governments and the general public who are relying on our medical researchers to get us through this pandemic.

“In this report we look at over 200 research projects to demonstrate the depth and breadth of COVID-19 research underway in Australia right now,” Nadia Levin said.

The volume of coronavirus medical research is testament to long-term investment in Australia’s medical research capacity, but that it had come at a cost.

“The sudden ‘downing of tools’ that must happen when researchers are called upon to pivot their research towards an urgent pandemic throws existing projects, and their funding, off course. Like other parts of the economy, health and medical research is suffering.

“Research Australia is already talking to its members about how we re-design a medical research system which can withstand these crises because there is a very real possibility COVID-19 won’t be the only pandemic we see in our lifetime,” Nadia Levin said.

COVID-19 – How Australia’s health and medical research sector is responding


News - MedTech & Diagnostics

Hearts4heart takes aim at private system leaving patients to pay the price

Hearts4heart takes aim at health insurers leaving patients to pay the price

Health Industry Hub | September 4, 2026 |

Persistent advocacy by patient groups has prompted the Medical Services Advisory Committee (MSAC) to review the funding gaps for pulsed […]

More


News - MedTech & Diagnostics

Queensland first: Private hospital deploys Abbott's PFA in atrial fibrillation

Queensland first: Private hospitals deploy Abbott’s PFA in atrial fibrillation

Health Industry Hub | September 4, 2026 |

More Australians living with atrial fibrillation (AF) are gaining access to one of the latest advances in heart-rhythm treatment, with […]

More


News - Pharmaceuticals

Five years of HTA reform talk, Now comes the $47 billion question

Five years of HTA reform talk, now comes the $47 billion question

Health Industry Hub | September 4, 2026 |

Medicines Australia has put a $47 billion price tag on what it says Australia must invest to improve equitable access […]

More


News - Pharmaceuticals

New MFN deals raise the stakes for Australia’s delayed HTA reform

New MFN deals raise the stakes for Australia’s delayed HTA reform

Health Industry Hub | September 2, 2026 |

Four months after the US Trump administration concluded what was expected to be the final tranche of drug-pricing agreements with […]

More


This content is copyright protected. Please subscribe to gain access.